Malignant Somatic Transformation of a Teratoma 15 Years Following Completion Therapy for a Germ Cell Tumor

Abstract

Keywords

teratoma germ cell tumor malignant somatic transformation

Get full access to this article

View all access options for this article.

References

Kundu

SD.

Feldman

DR.

Carver

et al. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors. J Urol. 2015;193(2):513-518.doi:10.1016/j.juro.2014.08.081

http://www.ncbi.nlm.nih.gov/pubmed/25150639

Chaganti

RS.

Houldsworth

. Genetics and biology of adult human male germ cell tumors. Cancer Res. 2000;60(6):1475-4482.http://www.ncbi.nlm.nih.gov/pubmed/10749107

Oldenburg

Alfsen

GC.

Lien

et al. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol. 2003;21(17):3310-3317.doi:10.1200/JCO.2003.03.184

http://www.ncbi.nlm.nih.gov/pubmed/12947067